Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells
Open Access
- 1 January 1999
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 259 (1-2) , 143-148
Abstract
Elevated levels of the urokinase‐type plasminogen activator (uPA) in tumor cells are conductive to tumor cell spread and metastasis. In a previous study we observed that suppression of RelA dramatically reduced endogenous uPA synthesis in the human ovarian cancer cell line OV‐MZ‐6. Because the uPA promoter contains three potential Rel‐like protein binding motifs (RRBE, 5′‐NF‐κB, and 3′‐NF‐κB) we conducted the first thorough systematic uPA promoter analysis to examine the direct impact of Rel proteins on uPA gene transcription. Disruption of RRBE resulted in a ∼40% decrease in uPA promoter activity, mutation of the 5′‐NF‐κB motif led to an additional 20% decrease. The 3′‐NF‐κB motif was not active. Overexpression of RelA significantly enhanced uPA promoter activity, whereas IκB‐α overexpression reduced uPA promoter activity by 40%. These data were supported by the finding that endogenous uPA was also increased sixfold by overexpression of RelA and decreased by 30% upon overexpression of IκB‐α. Transfection of OV‐MZ‐6 cells with antisense deoxynucleotides directed to RelA expression reduced uPA promoter activity by at least 40%. Our data clearly suggest that by binding to uPA promoter elements, Rel transcripton factors contribute directly to elevated uPA gene expression in human ovarian cancer cells, thereby promoting the multiple functions of uPA during tumor growth and metastasis.Keywords
This publication has 24 references indexed in Scilit:
- Signal transduction and the u-PA/u-PAR systemFibrinolysis, 1996
- Mechanism of the Tumor Necrosis Factor α-mediated Induction of Endothelial Tissue FactorJournal of Biological Chemistry, 1995
- Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)FEBS Letters, 1994
- Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasivenessBioEssays, 1993
- Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-κBScience, 1992
- Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell linesInternational Journal of Cancer, 1992
- Related subunits of NF-κB map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2Genomics, 1992
- B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50Cell, 1991
- Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblastsVirology, 1988
- Antibodies to plasminogen activator inhibit human tumor metastasisCell, 1983